Home Online Features CBC Group Completes Strategic Acquisition of UCB's Mature Product Portfolio in China
CBC Group Completes Strategic Acquisition of UCB’s Mature Product Portfolio in China
Hand-out
Press Releases
CBC Group  
November 30, 2024

CBC Group Completes Strategic Acquisition of UCB’s Mature Product Portfolio in China

CBC Group and Mubadala acquire UCB's mature neurology and allergy business in China for US$680 million.New company is named NeuroGen Pharma, led by an experienced management team with a strong

avatar profile Olean Times Herald

Olean Times Herald

email Olean Times Herald

Local & Social